Sort by
Refine Your Search
-
Listed
-
Field
-
in the Division of Proteomics of Stem Cells and cancer, headed by Prof. Jeroen Krijgsveld. Our division develops innovative proteomic approaches to understand proteome regulation in cancer, both in
-
resistance and relapse. Our ultimate goal is to develop new anti-leukemic therapies. We are searching for a highly motivated and dedicated student with a strong background in molecular biology and/or cell
-
cell sequencing datasets and to combine these data with AI analyses from bone marrow smears. We aim to analyze mechanisms and also to develop new biomarkers for therapy response and resistance. Job-ID
-
datasets (e.g. scRNA-seq) to derive prior knowledge on AML dormancy Develop and apply integrative data analysis pipelines (e.g. MOFA, Scriabin, LIANA+, COSMOS) for mining and interpreting multi-omic datasets
-
english (written and spoken) are expected We offer Goal-oriented, individual training and development opportunities Working with the latest techniques / technical equipment Possibility of doctorate
-
offer Goal-oriented, individual training and development opportunities Working with the latest techniques / technical equipment Possibility of doctorate Possibility to publish scientifically is offered
-
on the underlying molecular causes of cardiovascular diseases and the targeted development and translation of molecular therapies for clinical applications in cardiovascular diseases. The innovative research project
-
detection, diagnosis, and intervention for Autism Spectrum Disorders (ASD) and other conditions impacting social development. Supported by multiple funding bodies (e.g., DFG, BMBF, Rett Syndrome Foundation
-
soon as possible at the internal medicin for the Department of Cardiology, Angiology and Pneumology. The innovative research project focusses on the development and translation of a novel peptide therapy
-
to understand the role of microbiota in the development and therapy response of PDAC. We work in a highly motivated and international team in close collaboration with our colleagues at the German Cancer research